Attached files
| file | filename |
|---|---|
| EX-10.1 - SERACARE LIFE SCIENCES INC | v207980_ex10-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): December 31,
2010
SeraCare Life Sciences,
Inc.
(Exact
Name of Registrant as Specified in Charter)
|
Delaware
|
001-34105
|
33-0056054
|
||
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
file number)
|
(IRS
Employer
Identification
No.)
|
37 Birch Street, Milford,
Massachusetts 01757
(Address
of principal executive offices)
Registrant’s
telephone number, including area code: (508)
244-6400
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.142-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On
December 31, 2010, we entered into a severance agreement with William J. Smutny,
our former Vice President, Sales and Marketing, relating to the termination of
Mr. Smutny’s employment. The severance agreement provides that Mr.
Smutny’s employment with us terminated effective December 31,
2010. Mr. Smutny agreed to certain covenants, including
confidentiality and non-disparagement covenants, and provided a waiver and
release of claims against us. We agreed to pay Mr. Smutny severance
of $124,000, payable in equal installments over the thirteen scheduled bi-weekly
paydays following the effective date of the severance agreement. In
addition, the severance agreement provides that we will pay Mr. Smutny’s first
month of COBRA insurance premiums.
The
foregoing description of the severance agreement does not purport to be complete
and is qualified in its entirety by reference to the full text of the severance
agreement, which is attached to this current report as Exhibit 10.1 and is
incorporated by reference herein.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
(d) Exhibits.
|
Exhibit No.
|
Description
|
|
10.1
|
Severance
Agreement dated as of December 31, 2010 by and between SeraCare Life
Sciences, Inc. and William J.
Smutny.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
SERACARE
LIFE SCIENCES, INC.
|
|
|
By:
/s/ Gregory A.
Gould
|
|
|
Name:
Gregory A. Gould
|
|
|
Title: Chief
Financial Officer, Secretary and
Treasurer
|
Dated: January 12, 2011
EXHIBIT INDEX
|
Exhibit No.
|
Description
|
|
10.1
|
Severance
Agreement dated as of December 31, 2010 by and between SeraCare Life
Sciences, Inc. and William J.
Smutny.
|